NEW YORK, July 14 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. announces the following Webcast:
What: LHA Life Sciences & Med Tech Day 2010 Presentation When: July 20, 2010 @ 11:30 AM Eastern Where: http://www.investorcalendar.com/ClientPage.asp?ID=160488 Live over the Internet --Simply log on to the web at How: the address above. Contact: Cheryl Palazzo, 212-838-3777, cpalazzo@lhai.com
If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=160488 or http://www.investorcalendar.com/
Derma Sciences is a global medical device and pharmaceutical company focused on wound care. Its MEDIHONEY® product is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of indications, and was the focus of a positive large-scale, randomized controlled trial involving 108 leg ulcer patients. Other novel products introduced into the $14 billion global wound care market include XTRASORB® for better management of wound exudates, and BIOGUARD(TM) for infection prevention. Derma Sciences also expects to complete preclinical studies with DSC127, a novel pharmaceutical for accelerated wound healing and scar reduction, by the end of 2010. For more information please visit http://www.dermasciences.com/.
Derma Sciences, Inc.
CONTACT: Cheryl Palazzo, +1-212-838-3777, cpalazzo@lhai.com
Web Site: http://www.dermasciences.com/
